References in periodicals archive ?
CONTRAINDICATIONS DALVANCE is contraindicated in patients with known hypersensitivity to dalbavancin.
They were dalbavancin (Dalvance), approved in May; tedizolid (Sivextro), approved in June; and oritavancin (Orbactiv), approved in August.
There are some promising new therapies in late-stage trials, including Trius Therapeutics' tedizolid and Durata Therapeutics dalbavancin.
Two other lipoglycopeptides, dalbavancin and oritavancin, are not currently available and continue to be studied.
approval of dalbavancin last year after regulators said another trial was needed.
anidulafungin for fungal infections and dalbavancin for Gram-positive
NASDAQ: DRTX) today announced preliminary, top-line results for its DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response") Phase 3 study of dalbavancin, which is under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria, including MRSA (methicillin resistant Staphylococcus aureus).
Single dose treatment with dalbavancin for acute bacterial skin and skin structure infection (poster 785)
Ceftolozane/tazobactam is the 4th antibiotic to be FDA sanctioned in 2014, following approval of dalbavancin (Dalvance), tedizolid (Sivextro ), and oritavancin (Orbactiv).
Two - oritavancin and dalbavancin - are molecularly related to telavancin, which was approved in 2009.
After hearing comments from regulators last week, Pfizer said it decided to conduct an additional late-stage study of dalbavancin and withdraw applications for the product in the United States and Europe.
Vicuron products anidulafungin and dalbavancin under review by U.